We are live on ! Find out more
SBH

Segall Bryant & Hamill Portfolio holdings

AUM $6.98B
1-Year Est. Return 34.78%
This Fund
S&P 500
This Quarter Est. Return
-3.97%
1 Year Est. Return
+34.78%
3 Year Est. Return
+85.12%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.97%
AUM
$8.4B
AUM Growth
-$489M
Cap. Flow
+$10.4M
Cap. Flow %
0.12%
Top 10 Hldgs %
15.04%
Holding
758
New
34
Increased
325
Reduced
263
Closed
36

Top Sells

Rank Stock Value
1
ADBE icon
Adobe
ADBE
+$67.6M
2
SPGI icon
S&P Global
SPGI
+$31.4M
3
VYX icon
NCR Voyix
VYX
+$27.7M
4
CABO icon
Cable One
CABO
+$24.5M
5
CRL icon
Charles River Laboratories
CRL
+$19.8M

Sector Composition

Rank Sector Weight
1 Technology 17.8%
2 Healthcare 17.75%
3 Industrials 16.27%
4 Financials 13.04%
5 Consumer Discretionary 9.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.77T
$191M 2.28%
1,382,162
+48,685
+4% +$7.64M
MSFT icon
2
Microsoft
MSFT
$2.89T
$165M 1.97%
709,815
-14,950
-2% -$3.95M
AMZN icon
3
Amazon
AMZN
$2.62T
$157M 1.87%
1,386,565
-64,303
-4% -$8.13M
UNH icon
4
UnitedHealth
UNH
$395B
$125M 1.49%
247,475
+11,455
+5% +$6.02M
GOOG icon
5
Alphabet (Google) Class C
GOOG
$4.24T
$120M 1.43%
1,250,583
-83,097
-6% -$9.28M
EQC
6
DELISTED
Equity Commonwealth
EQC
$111M 1.32%
4,537,261
+128,558
+3% +$3.46M
PWR icon
7
Quanta Services
PWR
$96.3B
$110M 1.31%
866,664
-40,550
-4% -$5.54M
V icon
8
Visa
V
$676B
$97.1M 1.16%
546,382
-3,393
-0.6% -$690K
ZTS icon
9
Zoetis
ZTS
$31.3B
$94.1M 1.12%
634,767
+18,882
+3% +$3.16M
MRVL icon
10
Marvell Technology
MRVL
$191B
$92.4M 1.1%
2,154,485
-103,192
-5% -$5.11M
MTD icon
11
Mettler-Toledo International
MTD
$25.9B
$91.6M 1.09%
84,543
-13,775
-14% -$17.1M
RRX icon
12
Regal Rexnord
RRX
$14.3B
$90.4M 1.08%
643,960
+11,172
+2% +$1.5M
TMO icon
13
Thermo Fisher Scientific
TMO
$193B
$88.2M 1.05%
173,811
-21,657
-11% -$12.1M
ROP icon
14
Roper Technologies
ROP
$34.2B
$87.3M 1.04%
242,541
-34,253
-12% -$13.9M
DHR icon
15
Danaher
DHR
$124B
$85.8M 1.02%
374,560
+4,676
+1% +$1.14M
MCK icon
16
McKesson
MCK
$96.5B
$82.3M 0.98%
242,417
-11,477
-5% -$3.98M
ARES icon
17
Ares Management
ARES
$27B
$77.1M 0.92%
1,245,195
-94,319
-7% -$6.59M
PRGS icon
18
Progress Software
PRGS
$1.56B
$75.6M 0.9%
1,776,994
+37,038
+2% +$1.71M
CMP icon
19
Compass Minerals
CMP
$1.25B
$73.6M 0.88%
1,910,735
+53,031
+3% +$2.02M
JPM icon
20
JPMorgan Chase
JPM
$924B
$72M 0.86%
689,349
-143
-0% -$16.4K
TECH icon
21
Bio-Techne
TECH
$11.2B
$68M 0.81%
958,168
+89,204
+10% +$7.71M
SPXC icon
22
SPX Corp
SPXC
$10.9B
$67.8M 0.81%
1,227,977
+643
+0.1% +$36.8K
COTY icon
23
Coty
COTY
$2.39B
$65.5M 0.78%
10,359,938
-1,470,089
-12% -$11.1M
ZBRA icon
24
Zebra Technologies
ZBRA
$12.5B
$63.8M 0.76%
243,299
-5,324
-2% -$1.65M
BRK.B icon
25
Berkshire Hathaway Class B
BRK.B
$1.06T
$63.6M 0.76%
238,054
-7,177
-3% -$2.04M

Similar funds

Segall Bryant & Hamill's Q3 2022 Portfolio in Review

As of Q3 2022, Segall Bryant & Hamill held 758 positions worth $8.4B, down 5.5% from $8.88B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Segall Bryant & Hamill's Q3 2022 filing shows 34 new, 325 increased, 263 reduced and 36 closed positions. Its largest new stake was Ollie's Bargain Outlet: 570,889 shares worth $29.5M. The largest sale was Adobe, an estimated $67.6M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Healthcare and Industrials.

  • Segall Bryant & Hamill's largest Q3 2022 buy was Ollie's Bargain Outlet: 570,889 shares worth $29.5M.
  • Segall Bryant & Hamill added most to Novo Nordisk in Q3 2022, an estimated $27.4M increase.
  • Segall Bryant & Hamill's biggest Q3 2022 reduction was Adobe, cutting an estimated $67.6M.
  • Segall Bryant & Hamill fully exited Beacon Roofing Supply, Inc. in Q3 2022, selling an estimated $11.9M.
  • Segall Bryant & Hamill's ten largest holdings make up 15% of its $8.4B portfolio in Q3 2022.
  • Segall Bryant & Hamill opened 34 new positions and closed 36 in Q3 2022.
  • Segall Bryant & Hamill's portfolio value fell 5.5% quarter-over-quarter to $8.4B.

Based on Segall Bryant & Hamill's 13F filing for Q3 2022, filed 14 Nov 2022.